Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity.

J Endocrinol Invest

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Published: August 2022

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40618-022-01829-zDOI Listing

Publication Analysis

Top Keywords

reply letter
4
letter editor
4
editor terry
4
terry smith
4
smith teprotumumab
4
teprotumumab ototoxicity
4
reply
1
editor
1
terry
1
smith
1

Similar Publications

Reply to "The Letter of the Law: What Do We Know About Letters of Recommendation Quality for Hospitalist Sub-interns?".

J Gen Intern Med

January 2025

Section of Hospital Medicine, Department of Medicine, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave, Chicago, IL, 60637, USA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!